from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1139c/-

LFCtreatmentdescriptionclass of inhibitor

-1.054

Amikacinug/mL Amikacintranslation

-0.605

Cap5-10ug/mL Capreomycintranslation

0.440

Rox10-50 ug/mL Roxithromycintranslation

-0.640

SM2-5 ug/mL Streptomycintranslation

-0.756

Tet5-10 ug/mL Tetracyclinetranslation

0.512

Rif0.2-5ug/mL Rifampicintranscription

0.199

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.786

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.595

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.254

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.483

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.219

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.665

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.422

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.441

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.139

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.532

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.944

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.895

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.579

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.393

KCN5-20 ug/mL Potassium cyaniderespiration

0.686

NaN30.2-2 mM Sodium aziderespiration

-1.549

Nigericin50 uM Nigericinrespiration

-0.252

TRC10-150 ug/mL Triclosanrespiration

0.171

TRZ10-25 ug/mL Thioridazinerespiration

-0.191

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.509

menadione6-10 ug/mL Menadionerespiration

0.060

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.197

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.255

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.814

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.890

NRP_1Non-replicating persistence stage 1dosRassociated

0.116

Amp0.2mg/mL AmpicillincellWall

0.107

Cephalexin20-100 ug/mL CephalexincellWall

0.209

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.352

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.008

EMB10-20 ug/mL EthambutolcellWall

1.130

Eta12-40 ug/mL EthionamidecellWall

0.850

INH0.2-0.4 ug/mL IsoniazidcellWall

0.322

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.447

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.756

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.373

BZA0.12 mg/mL BenzamidearomaticAmides

-0.338

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.094

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.223

H2O24 mM hydrogen peroxideDNAdamaging

-0.096

Levo10 ug/mL LevofloxacinDNAdamaging

-0.317

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.315

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.431

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.332

UVUV-irradiationDNAdamaging

-0.880

ARP41-4 ug/mL Antitubercular compound ARP4?

0.070

Antimycin12.5-50 ug/mL Antimycin A?

0.030

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.081

PA_110-50 ug/mL Antitubercular compound PA-1?

0.750

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.842

PA8240.2-2 ug/mL PA-824?

-0.220

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.154

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.367

Verapamil50 uM Verapamil?

0.089

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.825

methoxatin10-20 ug/mL Methoxatin?